Ventripoint Diagnostics Ltd. (TSXV:VPT)

Canada flag Canada · Delayed Price · Currency is CAD
0.1100
-0.0050 (-4.55%)
Jun 5, 2025, 3:57 PM EDT
-52.17%
Market Cap 17.97M
Revenue (ttm) 166.49K
Net Income (ttm) -4.69M
Shares Out 163.38M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 298,075
Average Volume 102,884
Open 0.1050
Previous Close 0.1100
Day's Range 0.1000 - 0.1100
52-Week Range 0.0750 - 0.2450
Beta 0.27
RSI 40.89
Earnings Date Jun 5, 2025

About Ventripoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, in... [Read more]

Industry Medical Devices
Sector Healthcare
CEO Hugh MacNaught
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol VPT
Full Company Profile

Financial Performance

In 2024, Ventripoint Diagnostics's revenue was 95,172, an increase of 93.51% compared to the previous year's 49,183. Losses were -4.92 million, 0.98% more than in 2023.

Financial Statements

News

Ventripoint to Exhibit at the 58th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

Toronto, Ontario – TheNewswire – May 28, 2025 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce its participation in the 58th Annual Meeting...

8 days ago - TheNewswire

Ventripoint Expands Advisory Board with addition of Ultrasound AI Executive

Toronto, Ontario – TheNewswire - April 30, 2025 – Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) has increased the depth of its commercial experience with the add...

5 weeks ago - TheNewswire

Ventripoint Provides Corporate Update and Announces Shareholder Teleconference

Toronto, Canada — April 10, 2025 — TheNewswire - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) , a leading provider of innovative cardiac diagnostic solutions, i...

2 months ago - TheNewswire

Ventripoint Appoints Nicolas Coutin to Oversee Clinical Affairs

Toronto, Ontario – TheNewswire - April 8, 2025 – Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) today announced that it has appointed Nic Coutin, PhD. to oversee ...

2 months ago - TheNewswire

Ventripoint Makes Application to Amend Warrants

Toronto, Ontario, April 3, 2025 – TheNewswire - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT; OTC:VPTDF)  announces that it has made an application to the TSX Venture E...

2 months ago - TheNewswire

Ventripoint Diagnostics Publishes Whitepaper on the Use of AI in Whole-Heart Analysis

Toronto, Ontario – TheNewswire - March 24, 2025 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT; OTC:VPTDF) is pleased to announce the release of a whitepaper comparing ...

2 months ago - TheNewswire

Ventripoint Announces Closing of $500,000 Non-Brokered Convertible Debenture Unit Private Placement

Toronto, Ontario, March 21, 2025 – TheNewswire - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”, TSXV:VPT) announces the closing of its previously announced (see press release of...

2 months ago - TheNewswire

Ventripoint Announces Non-Brokered Convertible Debenture Units Private Placement

Toronto, Ontario – TheNewswire - March 14, 2025 – Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) , ( TSXV:VPT) announces a non-brokered private placement of up to CDN$500,000 (...

2 months ago - TheNewswire

Ventripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+(TM) 4.0 Automated Radiological Image Processing Software/System

Toronto, Ontario  - TheNewswire - February 27, 2025 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT; OTC:VPTDF) is pleased to announce that it has received U.S. Food and...

3 months ago - TheNewswire

Ventripoint Issues Option Grants and Reports Exercise of Options

Toronto, Ontario – TheNewswire – February 11, 2024  - Ventripoint Diagnostics Ltd. (“ Ventripoint  ” or the “  Corporation  ”)(TSXV:VPT, OTC:VPTDF) announces that on January 20, 2025, the Corporation ...

4 months ago - TheNewswire

Ventripoint Diagnostics issues shares for payment of debenture interest

Ventripoint Diagnostics issues shares to pay interest on convertible debentures, with shares priced at $0.11 subject to TSXV approval.

5 months ago - Seeking Alpha